Center for Scientific Review; Notice of Closed Meetings, 9526-9527 [2018-04465]
Download as PDF
<![CDATA[
9526
Federal Register / Vol. 83, No. 44 / Tuesday, March 6, 2018 / Notices
Amy McNulty,
Acting Director, Division of the Executive
Secretariat.
HRSA provided additional
grant funds to 4 award recipients in
Puerto Rico with project periods ending
in fiscal year 2018 to extend their
current project periods by 12 months to
prevent interruptions in the provision of
critical health care services while they
recover from Hurricane Maria.
SUPPLEMENTARY INFORMATION:
Recipients of the Award: Four Health
Center Program award recipients in
Puerto Rico vulnerable to a lapse in
service provision in their service areas
due to the impact of Hurricane Maria on
the operational resources available for
competitive application preparation for
fiscal year 2018, as listed in Table 1.
Amount of Non-Competitive Awards:
Four awards for $17,482,070.
Period of Supplemental Funding:
Fiscal year 2018.
CFDA Number: 93.224.
Authority: Section 330 of the Public
Health Service Act, as amended (42
U.S.C. 254b, as amended).
SUMMARY:
[FR Doc. 2018–04482 Filed 3–5–18; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Announcing Project Period Extensions
With Funding for Health Center
Program Award Recipients in Puerto
Rico; Health Center Program
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services (HHS).
AGENCY:
Announcing project period
extensions with Funding for Health
Center Program Award recipients in
Puerto Rico.
ACTION:
Justification: In September 2017, HHS
declared a hurricane-related public
health emergency in Puerto Rico. Health
centers in Puerto Rico and the patients
they serve continue to face significant
challenges associated with recovery
from Hurricane Maria. For these four
award recipients, the funding permits
them to continue to operate in the
current fiscal year before submitting
competitive applications by the end of
the 12-month extension period.
Extending the project period and
providing flexibility for competing
applications for these four award
recipients aligns with the Office of
Management and Budget’s
memorandum to provide short-term
relief to affected award recipients,
‘‘Administrative Relief for Grantees
Impacted by Hurricanes Harvey, Irma,
and Maria,’’ signed on October 26, 2017.
HRSA awarded approximately $17
million to the four existing Health
Center Program award recipients noted
in Table 1.
TABLE 1—RECIPIENTS AND AWARD AMOUNTS
Grant No.
H80CS00382
H80CS00695
H80CS00598
H80CS22687
.............
.............
.............
.............
Award recipient name
Morovis Community Health Center, Inc .......................................................................................
HPM Foundation, Inc ...................................................................................................................
Salud Integral en la Montana, Inc ................................................................................................
Corporacion de Salud Asegurada por Nuestra Organizacin Solidaria, Inc. (S.A.N.O.S.) ...........
FOR FURTHER INFORMATION CONTACT:
Olivia Shockey, Expansion Division
Director, Office of Policy and Program
Development, Bureau of Primary Health
Care, Health Resources and Services
Administration, at oshockey@hrsa.gov
or 301–594–4300.
Dated: February 27, 2018.
George Sigounas,
Administrator.
[FR Doc. 2018–04507 Filed 3–5–18; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
sradovich on DSK3GMQ082PROD with NOTICES
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
VerDate Sep<11>2014
State
21:39 Mar 05, 2018
Jkt 244001
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Topics in
Pathogenic Eukaryotes.
Date: March 13, 2018.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Tera Bounds, Ph.D., DVM,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3198,
MSC 7808, Bethesda, MD 20892, 301 435–
2306, boundst@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Center for
Scientific Review Special Emphasis Panel—
Health Informatics SBIR/STTR Applications.
Date: March 26–27, 2018.
Time: 8:00 a.m. to 5:00 p.m.
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
PR
PR
PR
PR
Award amount
$2,561,918
4,938,854
7,720,986
2,260,312
Agenda: To review and evaluate grant
applications.
Place: Hotel Monaco Baltimore, 2 North
Charles Street, Baltimore, MD 21201.
Contact Person: Sudha Veeraraghavan,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, 301–435–1504,
sudha.veeraraghavan@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
Mobile and Connected Health Interventions
to Improve HIV Care.
Date: March 27, 2018.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Shalanda A. Bynum,
Ph.D., MPH, Scientific Review Officer, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3206,
Bethesda, MD 20892, 301–755–4355,
bynumsa@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Exploration
of Antimicrobial Therapeutics and
Resistance.
Date: March 28–29, 2018.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\06MRN1.SGM
06MRN1
sradovich on DSK3GMQ082PROD with NOTICES
Federal Register / Vol. 83, No. 44 / Tuesday, March 6, 2018 / Notices
Place: Westin St. Francis San Francisco on
Union Square, 335 Powell Street, San
Francisco, CA 94102.
Contact Person: Susan Daum, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Dr. Room 3202,
Bethesda, MD 20892, 301–827–7233,
susan.boyle-vavra@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Cardiovascular Respiratory
Sciences.
Date: March 28, 2018.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road, NW,
Washington, DC 20015.
Contact Person: Sara Ahlgren, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, RM 4136,
Bethesda, MD 20892, 301–435–0904,
sara.ahlgren@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Auditory Neuroscience.
Date: March 28, 2018.
Time: 9:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Kirk Thompson, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5184,
MSC 7844, Bethesda, MD 20892, 301–435–
1242, kgt@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Musculoskeletal Rehabilitation
Sciences.
Date: March 28, 2018.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Maria Nurminskaya, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, Bethesda, MD 20892, (301) 435–1222,
nurminskayam@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Toxicology
and Digestive, Kidney and Urological
Systems AREA Review.
Date: March 28, 2018.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Aiping Zhao, MD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2188,
MSC 7818, Bethesda, MD 20892–7818, (301)
435–0682, zhaoa2@csr.nih.gov.
VerDate Sep<11>2014
21:39 Mar 05, 2018
Jkt 244001
9527
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Academic
Research Enhancement Award.
Date: March 28, 2018.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Jian Cao, MD, Scientific
Review Officer, Center for Scientific Review,
6701 Rockledge Drive, Bethesda, MD 20892,
301–827–5902, caojn@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Cancer Research.
Date: March 28, 2018.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: C.L. Albert Wang, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4146,
MSC 7806, Bethesda, MD 20892, 301–435–
1016, wangca@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Date: March 15–16, 2018.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute, Shady
Grove, 9609 Medical Center Drive, Room
7W554, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Christopher L. Hatch,
Ph.D., Scientific Review Officer, Program
Coordination & Referral Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W554, Bethesda, MD 20892–9750.
240–276–6454, ch29v@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: February 28, 2018.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
BILLING CODE 4140–01–P
[FR Doc. 2018–04465 Filed 3–5–18; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; U01–U24:
Translational Research for Liver Cancer
Detection.
Frm 00054
Fmt 4703
[FR Doc. 2018–04466 Filed 3–5–18; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
BILLING CODE 4140–01–P
PO 00000
Dated: February 28, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
Sfmt 4703
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA–RM–
17–015: Metabolomics Core for the
Undiagnosed Diseases Network (UDN) Phase
II.
Date: March 6, 2018.
Time: 1:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\06MRN1.SGM
06MRN1
]]>Agencies
[Federal Register Volume 83, Number 44 (Tuesday, March 6, 2018)]
[Notices]
[Pages 9526-9527]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-04465]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Topics in Pathogenic Eukaryotes.
Date: March 13, 2018.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Tera Bounds, Ph.D., DVM, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3198, MSC 7808, Bethesda, MD
20892, 301 435-2306, [email protected].
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Center for Scientific Review Special Emphasis Panel--Health
Informatics SBIR/STTR Applications.
Date: March 26-27, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hotel Monaco Baltimore, 2 North Charles Street,
Baltimore, MD 21201.
Contact Person: Sudha Veeraraghavan, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, 301-435-1504,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR Panel: Mobile and Connected Health Interventions to
Improve HIV Care.
Date: March 27, 2018.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Shalanda A. Bynum, Ph.D., MPH, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3206, Bethesda, MD 20892, 301-
755-4355, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Exploration of Antimicrobial Therapeutics and Resistance.
Date: March 28-29, 2018.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
[[Page 9527]]
Place: Westin St. Francis San Francisco on Union Square, 335
Powell Street, San Francisco, CA 94102.
Contact Person: Susan Daum, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Dr. Room 3202, Bethesda, MD 20892, 301-827-7233,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Cardiovascular Respiratory Sciences.
Date: March 28, 2018.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military
Road, NW, Washington, DC 20015.
Contact Person: Sara Ahlgren, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, RM 4136, Bethesda, MD 20892, 301-435-0904,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Auditory Neuroscience.
Date: March 28, 2018.
Time: 9:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kirk Thompson, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5184, MSC 7844, Bethesda, MD 20892, 301-435-
1242, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Musculoskeletal Rehabilitation Sciences.
Date: March 28, 2018.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892.
Contact Person: Maria Nurminskaya, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, Bethesda, MD 20892, (301) 435-1222,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Toxicology and Digestive, Kidney and Urological Systems AREA
Review.
Date: March 28, 2018.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Aiping Zhao, MD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 2188, MSC 7818, Bethesda, MD 20892-7818, (301)
435-0682, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Academic Research Enhancement Award.
Date: March 28, 2018.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jian Cao, MD, Scientific Review Officer, Center
for Scientific Review, 6701 Rockledge Drive, Bethesda, MD 20892,
301-827-5902, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Cancer Research.
Date: March 28, 2018.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: C.L. Albert Wang, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4146, MSC 7806, Bethesda, MD
20892, 301-435-1016, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: February 28, 2018.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-04465 Filed 3-5-18; 8:45 am]
BILLING CODE 4140-01-P
